{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T03:12:13Z","timestamp":1784344333286,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,28]],"date-time":"2015-07-28T00:00:00Z","timestamp":1438041600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12913-015-0934-9","type":"journal-article","created":{"date-parts":[[2015,7,27]],"date-time":"2015-07-27T10:18:24Z","timestamp":1437992304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cost-effectiveness analysis of dabigatran and anticoagulation monitoring strategies of vitamin K antagonist"],"prefix":"10.1186","volume":"15","author":[{"given":"Miseric\u00f2rdia","family":"Carles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Brosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Carlos","family":"Souto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep Maria","family":"Garcia-Alamino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Guyatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Alonso-Coello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,28]]},"reference":[{"key":"934_CR1","doi-asserted-by":"crossref","unstructured":"Navarro JL, C\u00e9sar JM, Fern\u00e1ndez MA, Fontcuberta J, Reverter JC, Gol-Freixa J,\u00a0et al. Morbilidad y mortalidad en pacientes con tratamiento anticoagulante oral. Rev Esp Cardiol. 2007;60:1226\u201332.","DOI":"10.1157\/13113927"},{"key":"934_CR2","volume-title":"Documento de consenso y posicionamiento oficial de la AEHH y la SETH","author":"Mart\u00ednez-Brotons F (Coordinador)","year":"2002","unstructured":"Mart\u00ednez-Brotons F (Coordinador). Recomendaciones acerca del control del tratamiento anticoagulante oral Ambulatorio. In: Documento de consenso y posicionamiento oficial de la AEHH y la SETH. Barcelona: Asociaci\u00f3n Espa\u00f1ola de Hematolog\u00eda y Hemoterapia (AEHH). Sociedad Espa\u00f1ola de Trombosis y Hemostasia (SETH); 2002. Available at http:\/\/www.sehh.es\/archivos\/informacion_fehh_fondo_01.pdf. Accessed 7 July, 2015."},{"key":"934_CR3","volume-title":"Coagul\u00f3metros port\u00e1tiles. Revisi\u00f3n de la evidencia cient\u00edfica y evaluaci\u00f3n econ\u00f3mica de su uso en el autocontrol del tratamiento anticoagulante oral","author":"O De Sol\u00e0-Morales Serra","year":"2003","unstructured":"De Sol\u00e0-Morales Serra O, Elorza Ricart JM. Coagul\u00f3metros port\u00e1tiles. Revisi\u00f3n de la evidencia cient\u00edfica y evaluaci\u00f3n econ\u00f3mica de su uso en el autocontrol del tratamiento anticoagulante oral. Barcelona: Ag\u00e8ncia d\u2019Avaluaci\u00f3 de Tecnologia i Recerca M\u00e8diques. CatSalut. Departament de Sanitat i Seguretat Social. Generalitat de Catalunya; 2003."},{"key":"934_CR4","doi-asserted-by":"crossref","unstructured":"Linkins LA, Choi PT, Douketis JD. Clinical impact of bleending in patients taking oral anticoagulant therapy for Venus thromboembolism: a meta-analysis. Ann Intern Med. 2003;139:893\u2013900.","DOI":"10.7326\/0003-4819-139-11-200312020-00007"},{"key":"934_CR5","doi-asserted-by":"crossref","unstructured":"Reynolds MW, Fahrbach K, Hauch O, Wygant G, Estok R, Cella C,\u00a0et al. Warfarin aticoagulation and outcomes in patients with atrial fibrilation: a systematic review and metaanalysis. Chest. 2004;126:1938\u201345.","DOI":"10.1378\/chest.126.6.1938"},{"key":"934_CR6","doi-asserted-by":"crossref","unstructured":"Cannegieter SC, Rosendaal FR, Wintzen AR,\u00a0van der Meer FJ,\u00a0Vandenbroucke JP,\u00a0Bri\u00ebt E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med. 1995;333:11\u20137.","DOI":"10.1056\/NEJM199507063330103"},{"key":"934_CR7","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1023\/A:1018778914477","volume":"9","author":"GP Samsa","year":"2000","unstructured":"Samsa GP, Matchar DB. Relationships between test frequency and outcomes of anticoagulation: a literature review and commentary with implications for de design of randomized trials of patient self management. J Thromb Thrombolisys. 2000;9:283\u201392.","journal-title":"J Thromb Thrombolisys"},{"key":"934_CR8","doi-asserted-by":"crossref","unstructured":"Ageno W, Gallus AS, Wittkowsky A,\u00a0Crowther M,\u00a0Hylek EM,\u00a0Palareti G,\u00a0et al. Oral anticoagulant therapy. Chest. 2012;141(2_suppl):e44S\u201388.","DOI":"10.1378\/chest.11-2292"},{"key":"934_CR9","doi-asserted-by":"crossref","unstructured":"Caballero-Villarraso J, Villegas-Portero R, Rodr\u00edguez-Cantalejo F. Dispositivos de coagulometr\u00eda port\u00e1til en el seguimiento y control ambulatorio de la terapia anticoagulante oral: revisi\u00f3n sistem\u00e1tica. Aten Primaria. 2011;43:148\u201356.","DOI":"10.1016\/j.aprim.2010.03.017"},{"key":"934_CR10","doi-asserted-by":"publisher","unstructured":"Garcia-Alamino JM, Ward AM, Alonso-Coello P, Perera R, Bankhead C, Fitzmaurice D, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev. 2010. CD003839. doi:10.1002\/14651858.CD003839.pub2.","DOI":"10.1002\/14651858.CD003839.pub2"},{"key":"934_CR11","doi-asserted-by":"crossref","unstructured":"Regier DA, Sunderji R, Lynd LD,\u00a0Gin K,\u00a0Marra CA. Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy. CMAJ. 2006;174:1847\u201352.","DOI":"10.1503\/cmaj.051104"},{"key":"934_CR12","doi-asserted-by":"crossref","unstructured":"Brown A, Wells P, Jaffey J, McGahan L, Poon M-C, Cimon K,\u00a0et al. Devices for point-of-care monitoring of long term oral anticoagulation therapy: clinical and cost effectiveness [Technology overview number 24]. Ottawa: Canadian Agency for Drugs and Technologies in Health; 2007.","DOI":"10.2139\/ssrn.992909"},{"key":"934_CR13","doi-asserted-by":"crossref","unstructured":"Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy. Antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e152S\u201384.","DOI":"10.1378\/chest.141.4.1129b"},{"key":"934_CR14","first-page":"e1","volume":"63:1483","author":"Grupo de trabajo para el manejo de la fibrilaci\u00f3n auricular de la Sociedad Europea de Cardiolog\u00eda (SEC)","year":"2010","unstructured":"Grupo de trabajo para el manejo de la fibrilaci\u00f3n auricular de la Sociedad Europea de Cardiolog\u00eda (SEC). Gu\u00edas de pr\u00e1ctica cl\u00ednica para el manejo de la fibrilaci\u00f3n auricular. Rev Esp Cardiol. 2010;63:1483:e1\u201383.","journal-title":"Rev Esp Cardiol"},{"key":"934_CR15","doi-asserted-by":"crossref","unstructured":"Connolly SJ, Ezekowitz MD, Yusuf S,\u00a0Eikelboom J,\u00a0Oldgren J,\u00a0Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139\u201351.","DOI":"10.1056\/NEJMoa0905561"},{"key":"934_CR16","unstructured":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios. Criterios y recomendaciones generales para el uso de nuevos anticoagulantes orales en la prevenci\u00f3n del ictus y la embolia sist\u00e9mica en pacientes con fibrilaci\u00f3n auricular no valvular. Informe de utilidad terap\u00e9utica UT\/V4\/23122013, MSSI, 2013. Available at: http:\/\/www.aemps.gob.es\/medicamentosUsoHumano\/informesPublicos\/docs\/criterios-anticoagulantes-orales.pdf. Accessed 7 July, 2015."},{"key":"934_CR17","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1161\/CIRCULATIONAHA.110.985655","volume":"123","author":"SV Shah","year":"2011","unstructured":"Shah SV, Gage BF. Cost-effectiveness of dabigatran for stroke prophylaxis in atrial fibrillation. Circulation. 2011;123:2562\u201370.","journal-title":"Circulation"},{"key":"934_CR18","doi-asserted-by":"crossref","unstructured":"Freeman JV, Zhu RP, Owens DK,\u00a0Garber AM,\u00a0Hutton DW,\u00a0Go AS,\u00a0et al. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Ann Intern Med. 2011;154:1\u201311.","DOI":"10.7326\/0003-4819-154-1-201101040-00289"},{"key":"934_CR19","doi-asserted-by":"crossref","unstructured":"Sorensen SV, Kansal AR, Connolly S,\u00a0Peng S,\u00a0Linnehan J,\u00a0Bradley-Kennedy C,\u00a0et al. Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. Thromb Haemost. 2011;105:908\u201319.","DOI":"10.1160\/TH11-02-0089"},{"key":"934_CR20","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Juanatey JR, \u00c1lvarez-Sabin J, Lobos JM,\u00a0Mart\u00ednez-Rubio A,\u00a0Reverter JC,\u00a0Oyag\u00fcez I,\u00a0et al. An\u00e1lisis coste-efectividad de dabigatran para la prevenci\u00f3n de ictus y embolia sist\u00e9mica en fibrilaci\u00f3n auricular no valvular en Espa\u00f1a. Rev Esp Cardiol. 2012;65:901\u201310.","DOI":"10.1016\/j.recesp.2012.06.006"},{"key":"934_CR21","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1160\/TH12-01-0027","volume":"108","author":"P Alonso-Coello","year":"2012","unstructured":"Alonso-Coello P, Zhou Q, Guyatt G. Home-monitoring of oral anticoagulation vs. dabigatran: an indirect comparison. Thromb Haemost. 2012;108:647\u201353.","journal-title":"Thromb Haemost"},{"key":"934_CR22","doi-asserted-by":"crossref","unstructured":"Guyatt GH, Oxman AD, Vist GE,\u00a0Kunz R,\u00a0Falck-Ytter Y,\u00a0Alonso-Coello P,\u00a0et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008;336(7650):924\u20136.","DOI":"10.1136\/bmj.39489.470347.AD"},{"key":"934_CR23","volume-title":"Actitudes y percepciones de los pacientes y m\u00e9dicos sobre los riesgos y beneficios del tratamiento anticoagulante oral: una revisi\u00f3n sistem\u00e1tica cualitativa","author":"E San Arderiu","year":"2012","unstructured":"San Arderiu E, Esfedaque Montes MB, Mas Dalmau G, Sol\u00e0 Arnau I, Alonso Coello P. Actitudes y percepciones de los pacientes y m\u00e9dicos sobre los riesgos y beneficios del tratamiento anticoagulante oral: una revisi\u00f3n sistem\u00e1tica cualitativa. Bilbao: XXXII Congreso de la Sociedad Espa\u00f1ola de Medicina de Familia y Comunitaria; 2012."},{"key":"934_CR24","doi-asserted-by":"crossref","first-page":"518","DOI":"10.33588\/rn.4309.2005830","volume":"43","author":"A Herv\u00e1s","year":"2006","unstructured":"Herv\u00e1s A, Cabas\u00e9s JM, Forc\u00e9n-Alonso T. Costes del ictus desde la perspectiva social. Enfoque de incidencia retrospectiva con seguimiento a tres a\u00f1os. Rev Neurol. 2006;43:518\u201325.","journal-title":"Rev Neurol"},{"key":"934_CR25","unstructured":"Ministerio de Sanidad y Consumo. Explotaci\u00f3n del CMBD. Pesos del 2003. Available at: http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/cmbdhome.htm. Accessed 7 July, 2015."},{"issue":"Suppl 1","key":"934_CR26","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1023\/A:1018704318655","volume":"9","author":"JE Lafata","year":"2000","unstructured":"Lafata JE, Martin SA, Kaatz S,\u00a0Ward RE. Anticoagulation clinics and patient self-testing for patients on chronic warfarin therapy: a cost-effectiveness analysis. J Thromb Thrombolysis. 2000;9 Suppl 1:S13\u20139.","journal-title":"J Thromb Thrombolysis"},{"key":"934_CR27","doi-asserted-by":"crossref","unstructured":"Jowet S, Bryan S, Murray E,\u00a0McCahon D,\u00a0Raftery J,\u00a0Hobbs FD,\u00a0et al. Patient self-management of anticoagulation therapy: a trial based cost-effectiveness analysis. BJH. 2006;134:632\u20139.","DOI":"10.1111\/j.1365-2141.2006.06243.x"},{"key":"934_CR28","unstructured":"National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. April 2013. Available at: http:\/\/publications.nice.org.uk\/pmg9 Accessed 7 July, 2015."},{"key":"934_CR29","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1177\/027298902400448867","volume":"22","author":"AH Briggs","year":"2002","unstructured":"Briggs AH, Goeree R, Blackhouse G,\u00a0O'Brien BJ. Probabilistic analysis of cost-effectiveness models: choosing between treatment strategies for gastroesophageal reflux disease. Med Decis Making. 2002;22:290\u2013308.","journal-title":"Med Decis Making"},{"key":"934_CR30","doi-asserted-by":"crossref","unstructured":"Sacrist\u00e1n JA, Oliva J, Del Llano J,\u00a0Prieto L,\u00a0Pinto JL. \u00bfQu\u00e9 es una tecnolog\u00eda sanitaria eficiente en Espa\u00f1a? Gac San. 2002;16:334\u201343.","DOI":"10.1016\/S0213-9111(02)71933-X"},{"key":"934_CR31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1055\/s-2007-996432","volume":"25","author":"U Taborski","year":"1999","unstructured":"Taborski U, Wittstamm FJ, Bernardo A. Cost-effectiveness of self-managed anticoagulant therapy in Germany. Semin Thromb Hemost. 1999;25:103\u20137.","journal-title":"Semin Thromb Hemost"},{"key":"934_CR32","doi-asserted-by":"crossref","unstructured":"Samsa GP, Matchar DB, Phillips DL,\u00a0McGrann J. Which approach to anticoagulation management is best? Illustration of an interactive mathematical model to support informed decision-making. J Thromb Thrombolysis. 2002;14:103\u201311.","DOI":"10.1023\/A:1023276710895"},{"key":"934_CR33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1157\/13072418","volume":"124","author":"O De Sola-Morales","year":"2005","unstructured":"De Sola-Morales O, Elorza JM. Portable coagulometers: a systematic review of the evidence on self-management of oral anticoagulant treatment. Med Clin (Barc). 2005;124:321\u20135.","journal-title":"Med Clin (Barc)"},{"key":"934_CR34","doi-asserted-by":"crossref","unstructured":"Connock M, Stevens C, Fry-Smith A,\u00a0Jowett S,\u00a0Fitzmaurice D,\u00a0Moore D,\u00a0et al. Clinical effectiveness and cost-effectiveness of different models of managing long- term oral anticoagulation therapy: a systematic review and economic modelling. Health Technol Assess. 2007;11:iii-iv,ix-66.","DOI":"10.3310\/hta11380"},{"key":"934_CR35","doi-asserted-by":"crossref","unstructured":"Claes N, Moeremans K, Frank B,\u00a0Jef A,\u00a0Jos V,\u00a0Herman VL,\u00a0et al. Estimating the cost-effectiveness of quality-improving interventions in oral anticoagulation management within general practice. Value Health. 2006;9:369\u201376.","DOI":"10.1111\/j.1524-4733.2006.00129.x"},{"key":"934_CR36","doi-asserted-by":"crossref","unstructured":"You JJ, Singer DE, Howard PA,\u00a0Lane DA,\u00a0Eckman MH,\u00a0Fang MC,\u00a0et al. Antithrombotic therapy for atrial fibrillation: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2012;141(suppl):e531S\u201375.","DOI":"10.1378\/chest.141.4.1129b"},{"key":"934_CR37","doi-asserted-by":"publisher","unstructured":"Alonso-Coello P, Montori VM, D\u00edaz MG,\u00a0Devereaux PJ,\u00a0Mas G,\u00a0Diez AI,\u00a0et al. Values and preferences for oral anti-thrombotic therapy in patients with atrial fibrillation: physician and patient perspectives. Health Expect. 2014. doi:10.1111\/hex.12201.","DOI":"10.1111\/hex.12201"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12913-015-0934-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0934-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-015-0934-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T18:51:27Z","timestamp":1748544687000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-015-0934-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,28]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["934"],"URL":"https:\/\/doi.org\/10.1186\/s12913-015-0934-9","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,28]]},"assertion":[{"value":"7 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"289"}}